Aster Capital Management (Difc) LTD Acadia Pharmaceuticals Inc Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 4,431 shares of ACAD stock, worth $109,002. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,431
Previous 40,609
89.09%
Holding current value
$109,002
Previous $745 Million
88.35%
% of portfolio
0.02%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
355Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.05 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$374 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$297 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$210 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$172 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.98B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...